Michael Shepard
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Immunology top 10%
- Immune Response and Inflammation
- Immunotherapy and Immune Responses
Papers in
- Oncology 5
- Co-authors
- L Souza (2 shared papers)Reinhold Munker (2 shared papers)HP Koeffler (2 shared papers)Dennis J. Slamon (2 shared papers)Gerhard Zugmaier (1 shared paper)Ruth Lupu (1 shared paper)Rámón Colomer (1 shared paper)Marc E. Lippman (1 shared paper)
- Journals
- Cancer Research (5 papers)Blood (2 papers)Journal of Clinical Oncology (1 paper)European Journal of Cancer (1 paper)Journal of Bone and Mineral Research (1 paper)
- Partner nations
- United StatesItaly
In The Last Decade
Michael Shepard
12 papers receiving 745 citations
Peers
Comparison fields: 5 of 67
- Oncology 382
- Immunology 259
- Hematology 113
- Radiology, Nuclear Medicine and Imaging 217
- Immunology and Allergy 54
Countries citing papers authored by Michael Shepard
This map shows the geographic impact of Michael Shepard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Shepard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Shepard more than expected).
Fields of papers citing papers by Michael Shepard
This network shows the impact of papers produced by Michael Shepard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Shepard. The network helps show where Michael Shepard may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Shepard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1990 | 265 | |
| 2 | 1987 | 192 | |
| 3 | 1987 | 173 | |
| 4 | Radiolabeled antibody targeting of the HER-2/neu oncoprotein. | 1992 | 101 |
| 5 | 1990 | 33 | |
| 6 | 2016 | 9 | |
| 7 | 2017 | 3 | |
| 8 | 2004 | 3 | |
| 9 | 2011 | 2 | |
| 10 | 2011 | 1 | |
| 11 | 2010 | 1 | |
| 12 | 2016 | 1 | |
| 13 | 2008 | 0 |
About Michael Shepard
Michael Shepard is a scholar working on Molecular Biology, Oncology, Cancer Research, Cell Biology and Immunology, having authored 13 papers that have together received 784 indexed citations. Recurring topics across this work include Proteoglycans and glycosaminoglycans research (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Adenosine and Purinergic Signaling (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Cancer Research and Treatments (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Immune Cell Function and Interaction (2 papers) and Immune Response and Inflammation (2 papers). The work is most often cited by research in Oncology (382 citations), Immunology (259 citations), Hematology (113 citations), Radiology, Nuclear Medicine and Imaging (217 citations) and Immunology and Allergy (54 citations). Michael Shepard has collaborated with scholars based in United States and Italy. Frequent co-authors include L Souza, Reinhold Munker, HP Koeffler, Dennis J. Slamon, Gerhard Zugmaier, Ruth Lupu, Rámón Colomer, Marc E. Lippman, Jay Sarup and Judith C. Gasson. Their work appears in journals such as Cancer Research, Blood, Journal of Clinical Oncology, European Journal of Cancer and Journal of Bone and Mineral Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.